We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Health

Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy

Last updated: January 28, 2025 1:19 pm
Editorial Board Published January 28, 2025
Share
SHARE

A photograph of Natsumeda lab members, together with Dr. Satoshi Shibuma (far left) and Dr. Manabu Natsumeda (far proper). Credit score: Niigata College

A bunch led by the Division of Neurosurgery, Mind Analysis Institute, Niigata College, has succeeded within the prognosis of leptomeningeal illness in diffuse midline gliomas by detecting H3K27M-mutant droplets from circulating tumor DNA of cerebrospinal fluid taken from these sufferers.

The work is printed within the journal Pediatric Blood & Most cancers on January 9, 2025.

In two sufferers, leptomeningeal illness was identified sooner than with conventional strategies reminiscent of MRI and cerebrospinal fluid cytology. In a single affected person, long run survival after the prognosis of leptomeningeal illness by early and aggressive intervention together with surgical procedure, radiation, and intrathecal supply of chemotherapeutic brokers led to long run survival.

A group led by Dr. Manabu Natsumeda used droplet digital PCR, a extremely delicate PCR system, to detect hint quantities of circulating tumor DNA from the cerebrospinal fluid of those sufferers.

“We found that detecting circulating tumor DNA in the cerebrospinal fluid of diffuse midline glioma patients was more difficult than other brain tumor patients such as primary central nervous system lymphoma and glioblastoma,” explains Dr. Natsumeda.

“However, when we were able to detect mutant tumor DNA, often the tumor had already spread to the cerebrospinal fluid, causing leptomeningeal disease. We think that early diagnosis and treatment of leptomeningeal disease in diffuse midline gliomas can improve survival.”

Extra info:
Satoshi Shibuma et al, Analysis of Leptomeningeal Illness in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid, Pediatric Blood & Most cancers (2025). DOI: 10.1002/pbc.31535

Offered by
Niigata College

Quotation:
Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy (2025, January 27)
retrieved 28 January 2025
from https://medicalxpress.com/information/2025-01-succeeds-early-diagnosis-leptomeningeal-disease.html

This doc is topic to copyright. Aside from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

You Might Also Like

Drug candidate holds promise for difficult-to-treat coronary heart illness

‘Groovy’ brains could also be extra environment friendly

Examine uncovers hyperlink between pathogen adaptation and autoimmune ailments in Han Chinese language

Classifying older adults requiring long-term care into 5 teams and clarifying their prognosis

Research highlights disparities in entry to superior life assist

TAGGED:biopsydiagnosisdiffusediseaseEarlygliomasleptomeningealLiquidmidlinestudysucceeds
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Opinion: Utah regulation permitting minors to revoke medical consent is ‘attacking the inspiration of the US well being care system’
Health

Opinion: Utah regulation permitting minors to revoke medical consent is ‘attacking the inspiration of the US well being care system’

Editorial Board February 5, 2025
Protein bars enriched with collagen have potential as a weight-loss help, research finds
With out clear water, Pacific Islanders flip to sugary drinks—tackling this might cut back weight problems
Britain’s Princess of Wales says her most cancers is in remission
To trigger most cancers or to not trigger most cancers: What results in H. pylori-induced abdomen malignancies?

You Might Also Like

Mind molecule offers new insights into migraine-related gentle sensitivity
Health

Mind molecule offers new insights into migraine-related gentle sensitivity

May 22, 2025
FDA approves Zynyz as first-line remedy for superior anal most cancers
Health

FDA approves Zynyz as first-line remedy for superior anal most cancers

May 21, 2025
Tumor-related epilepsy not a robust prognostic consider diffuse glioma, finds examine
Health

Tumor-related epilepsy not a robust prognostic consider diffuse glioma, finds examine

May 21, 2025
City areas in Missouri have greater charges of high-dose opioid prescriptions, examine finds
Health

City areas in Missouri have greater charges of high-dose opioid prescriptions, examine finds

May 21, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?